Belmont, CA, United States of America

Matt Kraft

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matt Kraft. Retrieved from https://idiyas.com/inventor/matt-kraft

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matt Kraft - Innovator in Polycyclic-Carbamoylpyridone Compounds

Introduction

Matt Kraft is a notable inventor based in Belmont, California. He has made significant contributions to the field of chemistry, particularly in the synthesis of polycyclic-carbamoylpyridone compounds. His innovative work has led to the development of methods for creating these complex compounds, which have various applications in pharmaceuticals.

Latest Patents

Matt Kraft holds one patent titled "Synthesis of polycyclic-carbamoylpyridone compounds." This patent discloses methods for making compounds of Formula I, showcasing his expertise in chemical synthesis and innovation.

Career Highlights

Matt is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead allows him to apply his inventive skills in a dynamic and impactful environment, contributing to advancements in medical science.

Collaborations

Throughout his career, Matt has collaborated with talented individuals such as Anna Chiu and John Enquist, Jr. These collaborations have fostered a creative environment that enhances innovation and drives research forward.

Conclusion

Matt Kraft is a distinguished inventor whose work in the synthesis of polycyclic-carbamoylpyridone compounds exemplifies the spirit of innovation in the pharmaceutical industry. His contributions continue to influence the field and inspire future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…